Answers are grounded in this paper and cite their sources.
BACKGROUND: Clinical trials in Duchenne muscular dystrophy (DMD) focus primarily on ambulant patients. Results cannot be extrapolated to later disease stages due to a decline in targeted muscle tissue. In non-ambulant DMD patients, hand function is relatively preserved and crucial for daily-life activities. We used quantitative MRI (qMRI) to establish whether the thenar muscles could be valuable to monitor treatment effects in non-ambulant DMD patients. METHODS: was determined using multiecho spin-echo. Clinical assessments at baseline (n = 17) and 12 months (n = 13) included pinch strength (kg), performance of the upper limb (PUL) 2.0, DMD upper limb patient reported outcome measure (PROM), and playing a video game for 10 min using a game controller. Group differences and correlations were assessed with non-parametric tests. RESULTS: (rho = 0.57, rho = 0.51, and rho = -0.59). Further studies are needed to relate these data to the loss of a clinically meaningful milestone.
No takes yet. Share an insight, caveat, or question.
Naarding et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: